[go: up one dir, main page]

WO1996015678A1 - Milk product enriched with ground eggshell - Google Patents

Milk product enriched with ground eggshell Download PDF

Info

Publication number
WO1996015678A1
WO1996015678A1 PCT/NL1995/000396 NL9500396W WO9615678A1 WO 1996015678 A1 WO1996015678 A1 WO 1996015678A1 NL 9500396 W NL9500396 W NL 9500396W WO 9615678 A1 WO9615678 A1 WO 9615678A1
Authority
WO
WIPO (PCT)
Prior art keywords
calcium
milk
eggshell
product
ground eggshell
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
PCT/NL1995/000396
Other languages
French (fr)
Inventor
Anne Schaafsma
Cornelis Glas
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
FrieslandCampina Nederland BV
Original Assignee
Friesland Brands BV
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority to NZ295758A priority Critical patent/NZ295758A/en
Priority to HK99102958.8A priority patent/HK1017828B/en
Priority to BR9509916A priority patent/BR9509916A/en
Priority to MX9703814A priority patent/MX9703814A/en
Priority to JP8516752A priority patent/JPH11504201A/en
Priority to SI9520125A priority patent/SI9520125A/en
Priority to FI972188A priority patent/FI972188A7/en
Priority to SK657-97A priority patent/SK65797A3/en
Priority to EP95937214A priority patent/EP0801529A1/en
Priority to CZ971564A priority patent/CZ156497A3/en
Application filed by Friesland Brands BV filed Critical Friesland Brands BV
Priority to AU39380/95A priority patent/AU689342B2/en
Publication of WO1996015678A1 publication Critical patent/WO1996015678A1/en
Priority to NO972357A priority patent/NO972357L/en
Priority to BG101506A priority patent/BG101506A/en
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23CDAIRY PRODUCTS, e.g. MILK, BUTTER OR CHEESE; MILK OR CHEESE SUBSTITUTES; MAKING OR TREATMENT THEREOF
    • A23C19/00Cheese; Cheese preparations; Making thereof
    • A23C19/06Treating cheese curd after whey separation; Products obtained thereby
    • A23C19/068Particular types of cheese
    • A23C19/076Soft unripened cheese, e.g. cottage or cream cheese
    • A23C19/0765Addition to the curd of additives other than acidifying agents, dairy products, proteins except gelatine, fats, enzymes, microorganisms, NaCl, CaCl2 or KCl; Foamed fresh cheese products
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23CDAIRY PRODUCTS, e.g. MILK, BUTTER OR CHEESE; MILK OR CHEESE SUBSTITUTES; MAKING OR TREATMENT THEREOF
    • A23C9/00Milk preparations; Milk powder or milk powder preparations
    • A23C9/12Fermented milk preparations; Treatment using microorganisms or enzymes
    • A23C9/13Fermented milk preparations; Treatment using microorganisms or enzymes using additives
    • A23C9/1322Inorganic compounds; Minerals, including organic salts thereof, oligo-elements; Amino-acids, peptides, protein-hydrolysates or derivatives; Nucleic acids or derivatives; Yeast extract or autolysate; Vitamins; Antibiotics; Bacteriocins
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23CDAIRY PRODUCTS, e.g. MILK, BUTTER OR CHEESE; MILK OR CHEESE SUBSTITUTES; MAKING OR TREATMENT THEREOF
    • A23C9/00Milk preparations; Milk powder or milk powder preparations
    • A23C9/152Milk preparations; Milk powder or milk powder preparations containing additives
    • A23C9/1522Inorganic additives, e.g. minerals, trace elements; Chlorination or fluoridation of milk; Organic salts or complexes of metals other than natrium or kalium; Calcium enrichment of milk

Definitions

  • This invention relates to foods based on milk products, which foods have an increased calcium content.
  • the object of the present invention is to provide milk product-based foods with an increased calcium content, which foods are intended to prevent well-known problems associated with a low calcium intake.
  • the object of the invention is to prepare tasty, calcium- enriched dairy products which are properly absorbable into the body, in order to guarantee a high calcium intake from a preventive, prophylactic point of view.
  • Dairy products having an increased calcium content are already known, for instance from European patent application 0 449 354. These known dairy products are enriched with inorganic calcium salts, such as CaC0 3 , CaCl2- Ca(OH)2, and Ca 3 (P0 4 ) 2 or organic calcic compounds, such as calcium gluconate, calcium citrate, calcium lactate, calcium malate, calcium ascorbate, and calcium glycerophosphate, as well as mixtures thereof.
  • inorganic calcium salts such as CaC0 3 , CaCl2- Ca(OH)2, and Ca 3 (P0 4 ) 2
  • organic calcic compounds such as calcium gluconate, calcium citrate, calcium lactate, calcium malate, calcium ascorbate, and calcium glycerophosphate, as well as mixtures thereof.
  • the invention relates to a milk product-based food which is supplemented with aseptically obtained and/or sterilized or low-germ fine ground eggshell.
  • ground eggshell originating from all species of birds can be used, the ground eggshell is preferably prepared from the shells of chicken eggs.
  • a typical analysis of ground eggshell derived from chicken eggs comprises about 38% calcium, 0.4% magnesium and 0.1% phosphorus.
  • the calcium is substantially present in the form of CaC0 3 .
  • EP-A-0 347 899 discloses pharmaceutical compositions for the treatment of diseases or ailments caused by calcium deficiency. While the object of the present invention is to provide a prophylactically active product, EP-A-0 347 899 is directed to more medical applications.
  • the product manufactured according to the known method is most effective in powder form and is preferably ingested orally. It does not teach anything from which a skilled person might infer that the use of the above-described eggshell product or in combination with dairy products leads to improved calcium absorption and retention of the total calcium fraction.
  • JP-60-259160 contain such a teaching.
  • This Japanese publication describes the fortification of bakery raw materials or raw materials for ground marine products to offer optimum processed foods for growing children, adolescents or pregnant and nursing mothers.
  • U.S. Patent 3,558,771 utilizes ground eggshell as wound- healing agent which is applied topically. Oral use in whatever form and for whatever purpose is neither mentioned nor suggested.
  • ground eggshell Because of the nature of the material to which the eggshell product is to be added, it is essential that aseptically obtained and/or sterile or low-germ ground eggshell be added. To that end, the ground eggshell need only be treated physically. Chemical treatments such as contacting the eggshells with strongly alkaline and/or oxidative agents as is prescribed, for instance, in Canadian patent specification 728,606, and in JP-53-44662, are not necessary, and are even undesired for not leading to optimal results and, in addition, considering the additional process steps.
  • the ground eggshell used in accordance with the invention is obtained under aseptic conditions and/or while killing the germs by thermization.
  • the milk product enriched with calcium from ground eggshell in accordance with the invention has a relatively high calcium concentration or calcium density.
  • Milk dry matter contains 1.2% calcium, 0.1% magnesium and 1% phosphorus, the greater part of the calcium being present colloidally in the form of phosphates.
  • amounts of about 3 g ground eggshell per 40 g dry matter can be added in order to obtain a calcium-enriched product of good taste.
  • the amount of ground eggshell that can be used in the products according to the invention depends on the consistency of the product to be enriched and on the mouthfeel which the enriched product is required to possess .
  • structured or more viscous milk products such as yoghurt, fresh cheese, spreads, pudding, mousses, custard and cheese, will contribute to preventing the relatively heavy ground eggshell from settling.
  • ground eggshell shoul d not be added in such an amount as to give rise to a more or less dry mouthfeel.
  • This amount of ground eggshell depends on the product. For instance, in fresh cheese the mouthfeel will change considerably less rapidly by the addition of a large amount of ground eggshell than in whole milk. The above aspects are moreover affected by the fineness of the ground eggshell.
  • the product according to the invention is also enriched with a magnesium source, such as a salt.
  • a magnesium source such as a salt.
  • Magnesium contributes to the maintenance of a slightly higher pH of the extracellular fluids in the body. Because of this somewhat higher pH, calcium phosphate salts from bone tissue will go into solution less rapidly. From the results of Example 8 (wide infra) it follows that magnesium digestibility is higher with ground eggshell as with another calcium source. Although ground eggshell already contains magnesium ions, additional magnesium sources, e.g. Mg-containing salts, have to be added to the eggshell-enriched dairy products in order to achieve a desired physiological Mg/Ca ratio of 1:3 to 1:12, inter alia with a view to optimum calcium retention.
  • JP-61-199762 focuses on the specific effect of vitamin K in the absorption of calcium, while dry milk is presented as source of essential amino acids.
  • JP-69-91861 relates to the combination of the amino acid glycin, citric acid, a lactic-acid-rich milk fraction and eggshells or oyster shells - as well as absorbable calcium granules.
  • Advantages are moreover gained when, with a view to good calcium retention, vitamin D or vitamin-D-rich raw material, such as fishliver oil, is added to the ground eggshell enriched dairy product.
  • lactose, a fluoride-, vanadium-, boron-, silicium-ion source or vitamin sources such as A, K, C can positively affect the maximum effect of the calcium enrichment.
  • the milk products that can be enriched according to the invention are liquid products, which may or may not be in concentrated, structured, highly viscous and/or fermented form. Structured or more viscous milk products, such as yoghurt, fresh cheese, spreads, pudding, mousses, custard and cheese, contribute, as stated, to non-settlement of the ground eggshell.
  • the milk product-based product according to the invention can moreover be brought into powdered form.
  • suitable milk raw materials for the preparation of the products according to the invention comprise whole milk, low- fat milk, skim milk, cream, whey and buttermilk. Derivatives thereof, such as caseins, casein phosphopeptides, whey proteins, lactose, desalted whey products, milk protein hydrolysates, milk fat fractions and butter oil, as well as the products mentioned in powder form, can also be used as raw material.
  • microingredients such as vitamins, minerals, flavors, amino acids (such as lysine, arginine, glycine, cysteine, ethionine), binders, emulsifiers, antioxidants, additional sugars, vegetable fats or proteins, dextrins, dietary fibers, etc.
  • a semifinished product was prepared by dissolving ground eggshell and maltodextrin MD 20 in low-fat milk and drying this by known methods on a wheel dryer to form a powder.
  • the semifinished product obtained was finally mixed with a conventional vitamin and mineral premix in dry form, such that the final product comprised:
  • a composition was obtained, which contained per 100 grams: 20.5% protein, 14% fat, 2400 mg Ca, 500 mg Mg, 7 mg Fe, 3 mg Zn, 250 ⁇ g Cu, 94 ⁇ g iodide, 500 IU D3, 2500 ⁇ g ⁇ -carotene, 2500 IE vitamin A, 25 mg vitamin E, 50 ⁇ g vitamin K, 2500 ⁇ g vitamin Bl, 4500 ⁇ g vitamin B2, 18750 ⁇ g niacin, 5000 ⁇ g vitamin B6, 500 ⁇ g folic acid, 5000 ⁇ g pantothenic acid, 5 ⁇ g vitamin B12, 75 ⁇ g biotin and 150 mg vitamin C.
  • the Ca:Mg ratio was 5:1.
  • Example I by mixing a product was prepared, starting from low-fat milk powder, a powder prepared by jointly drying ground eggshell and maltodextrin on a wheel dryer after priorl dissolving the maltodextrin and the ground eggshell in water, and the vitamin-mineral premix in dry form.
  • Example 3 Compared with the product according to Example I, a product of improved stability and appreciation was obtained, after a milk solution had been prepared from this powder.
  • Example 3
  • a powdered product was prepared under dry mixing of 6% whole milk powder, 30% powdered product prepared from skim milk and vegetable fat (rapeseed oil + olein + oil rich in eicosapentaenoic acid and docosahexaenoic acid), 31% skim milk powder, 20% desalted whey powder, 8% Fibruline R (containing soluble dietary fibers in the form of inulin), 2% fine ground eggshell and 3% vitamin-mineral premix.
  • skim milk and vegetable fat rapeseed oil + olein + oil rich in eicosapentaenoic acid and docosahexaenoic acid
  • skim milk powder 20% desalted whey powder
  • Fibruline R containing soluble dietary fibers in the form of inulin
  • 2% fine ground eggshell 3% vitamin-mineral premix.
  • the product comprised per 100 grams: 22.5% protein, 12.5% fat, 8% dietary fibers, 350 IUs vitamin D3.
  • the Ca:Mg ratio was 4:1.
  • a low-fat fresh cheese product was prepared, which contained 10 g milk proteins and 3.5 g carbohydrates per 100 g. Under stirring, per 100 g of this product, 3 g ground eggshell was aseptically added until a homogeneous product of good taste was obtained.
  • Example IV 3 g ground eggshell per 100 g was included in low-fat yoghurt which contained 4 g milk proteins, 4 g carbohydrates and 1.5 g milk fat per 100 g.
  • the thus prepared product was packaged in sticks .
  • a powdered premix-product was prepared, destinated for application in food products, for instance in meat and cakes, under dry mixing of 40% sodium caseinate, 40% eggshell and 20% magnesium premix based on lactose (milk sugar) .
  • the Ca:Mg-ratio was 4.0:1.0.
  • COFOK castrated male piglets
  • composition of fat mixture coconut fat 10%, tallow 35%, lard 35%, soybean oil 20%.
  • choline chloride 400 ⁇ g vitamin B 12 , 3 mg vitamin K, 50 mg vitamin C, 1 mg folic acid, 0.1 mg biotin, 2.5 mg CoS0 .7H 2 0, 0.2 mg Na 2 Se0 .5H 2 0, 0.5 mg KI , 400 mg FeSo .7H 2 0, 80 mg CuSo 4 .5H 2 0, 70 mg Mn0 2 , 200 mg ZnS0 4 .H 2 0.
  • the faeces of the piglets were collected in stoma bags which had been attached to the anus, and analysed. For the determination of the apparent digestibility of calcium, the total feed intake and the total amount of faeces per piglet were measured. The stoma bags were emptied daily.
  • the faeces were weighed and stored at -20°C until the end of the test period. Then the faeces were freeze-dried, ground, homogenized, sampled and analysed for calcium content and fat content according to known techniques. These contents were converted to wet faeces contents.
  • the digestibility coefficients (DC) of Ca, Mg and crude fat were calculated from the amounts of Ca, Mg and crude fat in the diets, the amounts of these components in the wet faeces, the feed intake of the piglet and the amount of faeces produced bv that piglet.
  • the average DC was determined per group.
  • Table 2 summarizes the apparent DCs of calcium, magnesium and crude fat.
  • the digestibility of calcium and magnesium is higher in piglets that were given ground eggshell as calcium source than in the piglets that were given C C ⁇ 3 >98%.

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Food Science & Technology (AREA)
  • Polymers & Plastics (AREA)
  • Microbiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Nutrition Science (AREA)
  • Health & Medical Sciences (AREA)
  • Inorganic Chemistry (AREA)
  • Biochemistry (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Dairy Products (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Preparation Of Fruits And Vegetables (AREA)
  • Fodder In General (AREA)
  • Closures For Containers (AREA)
  • Non-Alcoholic Beverages (AREA)

Abstract

The invention relates to the use of aseptic or sterile fine ground eggshell in foods based on milk products. As a result, products of good taste are obtained, which are enriched with calcium and which give improved calcium absorption and retention of the total calcium fraction compared with milk product-based food products enriched with calcium from other calcium sources.

Description

Title: Milk product enriched with ground eggshell.
This invention relates to foods based on milk products, which foods have an increased calcium content.
It is generally known that milk products make an essential contribution to the calcium supply of man. When milk products are used as the only calcium source, however, a considerable amount of this calcium source must be consumed. In order to ingest the recommended daily dose of calcium, it would be necessary, for instance, to drink 1 to 1.25 liters of milk. There is a large group of people who consume only few dairy products. In addition, partly as a consequence of the proportional increase of the ageing population, there is an increase in the number of people for whom it is important to take in sufficient calcium to prevent physical ailments caused by a deficiency of calcium ions. One of these physical ailments is osteoporosis.
In the light of the above, there is a need for dairy products which are enriched with calcium.
Accordingly, the object of the present invention is to provide milk product-based foods with an increased calcium content, which foods are intended to prevent well-known problems associated with a low calcium intake. In particular, the object of the invention is to prepare tasty, calcium- enriched dairy products which are properly absorbable into the body, in order to guarantee a high calcium intake from a preventive, prophylactic point of view.
Dairy products having an increased calcium content are already known, for instance from European patent application 0 449 354. These known dairy products are enriched with inorganic calcium salts, such as CaC03, CaCl2- Ca(OH)2, and Ca3(P04)2 or organic calcic compounds, such as calcium gluconate, calcium citrate, calcium lactate, calcium malate, calcium ascorbate, and calcium glycerophosphate, as well as mixtures thereof. In accordance with the invention, it has now surprisingly been found that when fine ground eggshell is used as calcium source for dairy products, a product is obtained which gives improved calcium absorption and retention of the total calcium fraction in the consumer's body compared with the known dairy products enriched with calcium from other calcium sources.
In general, for preventive use of ground eggshell a daily intake of approximately 3 g egg shell is recommended.
Accordingly, the invention relates to a milk product-based food which is supplemented with aseptically obtained and/or sterilized or low-germ fine ground eggshell.
Methods of preparing the type of ground eggshell which is used in the products according to the present invention are known. In this connection, in particular explicit reference is made to European patent application 0 347 899, U.S. Patent
3,558,7"U and JP-60-259160. Although in fact ground eggshell originating from all species of birds can be used, the ground eggshell is preferably prepared from the shells of chicken eggs. A typical analysis of ground eggshell derived from chicken eggs comprises about 38% calcium, 0.4% magnesium and 0.1% phosphorus. The calcium is substantially present in the form of CaC03.
EP-A-0 347 899 discloses pharmaceutical compositions for the treatment of diseases or ailments caused by calcium deficiency. While the object of the present invention is to provide a prophylactically active product, EP-A-0 347 899 is directed to more medical applications. In that patent application it is stated that the product manufactured according to the known method is most effective in powder form and is preferably ingested orally. It does not teach anything from which a skilled person might infer that the use of the above-described eggshell product or in combination with dairy products leads to improved calcium absorption and retention of the total calcium fraction. Neither does JP-60-259160 contain such a teaching. This Japanese publication describes the fortification of bakery raw materials or raw materials for ground marine products to offer optimum processed foods for growing children, adolescents or pregnant and nursing mothers.
U.S. Patent 3,558,771 utilizes ground eggshell as wound- healing agent which is applied topically. Oral use in whatever form and for whatever purpose is neither mentioned nor suggested.
Because of the nature of the material to which the eggshell product is to be added, it is essential that aseptically obtained and/or sterile or low-germ ground eggshell be added. To that end, the ground eggshell need only be treated physically. Chemical treatments such as contacting the eggshells with strongly alkaline and/or oxidative agents as is prescribed, for instance, in Canadian patent specification 728,606, and in JP-53-44662, are not necessary, and are even undesired for not leading to optimal results and, in addition, considering the additional process steps. The ground eggshell used in accordance with the invention is obtained under aseptic conditions and/or while killing the germs by thermization. The milk product enriched with calcium from ground eggshell in accordance with the invention has a relatively high calcium concentration or calcium density. For instance, it is possible to increase the calcium content in whole milk to such an extent that an adult need only consume 500-700 ml milk, rather than about 1-1.25 liters, to achieve the required daily calcium intake. Milk dry matter contains 1.2% calcium, 0.1% magnesium and 1% phosphorus, the greater part of the calcium being present colloidally in the form of phosphates. In milk, amounts of about 3 g ground eggshell per 40 g dry matter can be added in order to obtain a calcium-enriched product of good taste.
In fact, the amount of ground eggshell that can be used in the products according to the invention depends on the consistency of the product to be enriched and on the mouthfeel which the enriched product is required to possess . For instance, structured or more viscous milk products, such as yoghurt, fresh cheese, spreads, pudding, mousses, custard and cheese, will contribute to preventing the relatively heavy ground eggshell from settling. Further, ground eggshell should not be added in such an amount as to give rise to a more or less dry mouthfeel. This amount of ground eggshell, too, depends on the product. For instance, in fresh cheese the mouthfeel will change considerably less rapidly by the addition of a large amount of ground eggshell than in whole milk. The above aspects are moreover affected by the fineness of the ground eggshell.
As already mentioned above, it has been found that ground eggshell leads to improved calcium absorption and retention of the total calcium fraction. This has been demonstrated on the basis of a comparison between the apparent faecal digestibility coefficients for ground eggshell and calcium carbonate as found in piglets. As is well-known ro those skilled in the art (see, for instance: Swine in biomedical research Volumes 1, 2 and 3 Plenum Press, New York, 1986. Ed. M.E. Tumbleson), piglets are suitable animal models for human food research. All this is further elaborated in Example 8 in particular.
In a preferred embodiment, the product according to the invention is also enriched with a magnesium source, such as a salt. Magnesium contributes to the maintenance of a slightly higher pH of the extracellular fluids in the body. Because of this somewhat higher pH, calcium phosphate salts from bone tissue will go into solution less rapidly. From the results of Example 8 (wide infra) it follows that magnesium digestibility is higher with ground eggshell as with another calcium source. Although ground eggshell already contains magnesium ions, additional magnesium sources, e.g. Mg-containing salts, have to be added to the eggshell-enriched dairy products in order to achieve a desired physiological Mg/Ca ratio of 1:3 to 1:12, inter alia with a view to optimum calcium retention.
Milk products in combination witn eggshell are described in JP-61-199762 and JP-59-91861 These prior art documents do, however, not point to any improved calcium absorption and/or -retention obtained from this specific combination.
Furthermore, there is no indication in these documents from which a skilled person would deduce a specific role of magnesium in bone metabolism.
In fact, JP-61-199762 focuses on the specific effect of vitamin K in the absorption of calcium, while dry milk is presented as source of essential amino acids.
JP-69-91861 relates to the combination of the amino acid glycin, citric acid, a lactic-acid-rich milk fraction and eggshells or oyster shells - as well as absorbable calcium granules. Advantages are moreover gained when, with a view to good calcium retention, vitamin D or vitamin-D-rich raw material, such as fishliver oil, is added to the ground eggshell enriched dairy product. Also, lactose, a fluoride-, vanadium-, boron-, silicium-ion source or vitamin sources such as A, K, C can positively affect the maximum effect of the calcium enrichment. The milk products that can be enriched according to the invention are liquid products, which may or may not be in concentrated, structured, highly viscous and/or fermented form. Structured or more viscous milk products, such as yoghurt, fresh cheese, spreads, pudding, mousses, custard and cheese, contribute, as stated, to non-settlement of the ground eggshell.
The milk product-based product according to the invention can moreover be brought into powdered form. Suitable milk raw materials for the preparation of the products according to the invention comprise whole milk, low- fat milk, skim milk, cream, whey and buttermilk. Derivatives thereof, such as caseins, casein phosphopeptides, whey proteins, lactose, desalted whey products, milk protein hydrolysates, milk fat fractions and butter oil, as well as the products mentioned in powder form, can also be used as raw material.
It is further possible to add known additives to the ground eggshell-enriched milk products, for instance microingredients such as vitamins, minerals, flavors, amino acids (such as lysine, arginine, glycine, cysteine, ethionine), binders, emulsifiers, antioxidants, additional sugars, vegetable fats or proteins, dextrins, dietary fibers, etc.
The invention will now be explained in more detail in and by the examples below. Unless otherwise stated, percentages and parts are always based on the weight of the total composition.
Example 1
A semifinished product was prepared by dissolving ground eggshell and maltodextrin MD 20 in low-fat milk and drying this by known methods on a wheel dryer to form a powder. The semifinished product obtained was finally mixed with a conventional vitamin and mineral premix in dry form, such that the final product comprised:
68 parts low-fat milk dry substance, 5 parts fine ground eggshell, 24 parts maltodextrin MD 20 and 3 parts vitamin and mineral premix.
A composition was obtained, which contained per 100 grams: 20.5% protein, 14% fat, 2400 mg Ca, 500 mg Mg, 7 mg Fe, 3 mg Zn, 250 μg Cu, 94 μg iodide, 500 IU D3, 2500 μg β-carotene, 2500 IE vitamin A, 25 mg vitamin E, 50 μg vitamin K, 2500 μg vitamin Bl, 4500 μg vitamin B2, 18750 μg niacin, 5000 μg vitamin B6, 500 μg folic acid, 5000 μg pantothenic acid, 5 μg vitamin B12, 75 μg biotin and 150 mg vitamin C. The Ca:Mg ratio was 5:1.
Example 2
In accordance with Example I, by mixing a product was prepared, starting from low-fat milk powder, a powder prepared by jointly drying ground eggshell and maltodextrin on a wheel dryer after priorl dissolving the maltodextrin and the ground eggshell in water, and the vitamin-mineral premix in dry form.
Compared with the product according to Example I, a product of improved stability and appreciation was obtained, after a milk solution had been prepared from this powder. Example 3
A powdered product was prepared under dry mixing of 6% whole milk powder, 30% powdered product prepared from skim milk and vegetable fat (rapeseed oil + olein + oil rich in eicosapentaenoic acid and docosahexaenoic acid), 31% skim milk powder, 20% desalted whey powder, 8% Fibruline R (containing soluble dietary fibers in the form of inulin), 2% fine ground eggshell and 3% vitamin-mineral premix.
The product comprised per 100 grams: 22.5% protein, 12.5% fat, 8% dietary fibers, 350 IUs vitamin D3. The Ca:Mg ratio was 4:1.
Example 4
A low-fat fresh cheese product was prepared, which contained 10 g milk proteins and 3.5 g carbohydrates per 100 g. Under stirring, per 100 g of this product, 3 g ground eggshell was aseptically added until a homogeneous product of good taste was obtained.
Then portion packages were filled with the thus prepared product. Example 5
In accordance with Example IV, 3 g ground eggshell per 100 g was included in low-fat yoghurt which contained 4 g milk proteins, 4 g carbohydrates and 1.5 g milk fat per 100 g.
Example 6
60 parts sugared condensed whole milk which contained 8% milk fat, 20% fat-free milk dry substance, 45% saccharose and 27% water, were mixed, under stirring, with 40 parts of a mixture consisting of 45% saccharose, 20% fine ground eggshell, 5% vitamin and mineral premix and 30% water until a homogeneous mass was obtained.
The thus prepared product was packaged in sticks .
Example 7
A powdered premix-product was prepared, destinated for application in food products, for instance in meat and cakes, under dry mixing of 40% sodium caseinate, 40% eggshell and 20% magnesium premix based on lactose (milk sugar) . The Ca:Mg-ratio was 4.0:1.0.
Example 6
For the purpose of determining the apparent digestibility of calcium, the following test was performed on piglets.
In this test aseptic ground eggshell was compared with calcium carbonate of a purity in excess of 98% (complexometrically determined) from Boom B.V., Meppel, Netherlands.
Fourteen castrated male piglets (COFOK), 5 weeks old, weighing about 10 kg, were placed in a metabolic cage with a Tenderfoot floor. In this cage the temperature was adjusted to 24°C, while the air humidity was maintained at a constant level. The metabolic cage was illuminated with daylight and fluorescent tubes between 8.00 and 17.00 hours.
After an acclimatisation period of 6 days and a pre-test period of 10 days, the following test was performed for 7 days. On the basis of their weight and general health condition, two groups of 6 piglets were selected from the 14 animals. Each group was given an experimental diet, one having 1% calcium carbonate, the other having 1% ground eggshell as most important calcium source. The piglets were fed twice a day, receiving an amount of feed 2.2 times as large as their normal energy requirement. The feed was given in a water:feed ratio of 2.5:1 and had the composition as summarized in Table 1. Table 1. Composition of diets (%)
Figure imgf000011_0001
1) Composition of fat mixture : coconut fat 10%, tallow 35%, lard 35%, soybean oil 20%.
2) Premix per 1 kg feed:
9000 IU vitamin A, 1800 IU vitamin D3, 40 mg vitamin E, 5 mg riboflavin, 30 mg niacin amide, 12 mg d-pantothenic acid,
350 mg choline chloride, 40 μg vitamin B12 , 3 mg vitamin K, 50 mg vitamin C, 1 mg folic acid, 0.1 mg biotin, 2.5 mg CoS0 .7H20, 0.2 mg Na2Se0 .5H20, 0.5 mg KI , 400 mg FeSo .7H20, 80 mg CuSo4.5H20, 70 mg Mn02 , 200 mg ZnS04.H20.
40 mg Tylosin.
The faeces of the piglets were collected in stoma bags which had been attached to the anus, and analysed. For the determination of the apparent digestibility of calcium, the total feed intake and the total amount of faeces per piglet were measured. The stoma bags were emptied daily.
The faeces were weighed and stored at -20°C until the end of the test period. Then the faeces were freeze-dried, ground, homogenized, sampled and analysed for calcium content and fat content according to known techniques. These contents were converted to wet faeces contents.
The digestibility coefficients (DC) of Ca, Mg and crude fat were calculated from the amounts of Ca, Mg and crude fat in the diets, the amounts of these components in the wet faeces, the feed intake of the piglet and the amount of faeces produced bv that piglet. The average DC was determined per group. Table 2 summarizes the apparent DCs of calcium, magnesium and crude fat.
Table 2. Apparent faecal digestibility coefficients of calcium, magnesium and crude fat in the diets.
Component Diet
I / CaC03 II / ground eggshell
Calcium 66.9 ± 7 9 71.3 ± 3.8 Magnesium 34.0 ± 4 6 36.3 ± 4.0 Crude fat 77.8 ± 2 1 78.3 ± 1.4
Values given as average ± standard deviation
The digestibility of calcium and magnesium is higher in piglets that were given ground eggshell as calcium source than in the piglets that were given C Cθ3 >98%.
By correction of the data to a recovery of chromium of
100% the differences in digestibility coefficients of calcium and magnesium became even larger (calcium 72.2 versus 66.7; maσnesium 38.2 versus 33.4 in advance of ground eggshell). The eggshell diet showed the same digestibility of the fat fraction as the calcium carbonate diet did.

Claims

C AIMS
1. A food based on milk products, which is supplemented with aseptically obtained and/or sterilized or low-germ fine ground eggshell.
2. A food according to claim 1, which is also enriched with a magnesium source, such as a magnesium salt.
3. A food according to claim 1 or 2, which is also enriched with vitamin D.
4. A food according to any one of the preceding claims, which food is derived from whole milk, low-fat milk, skim milk, cream, whey and/or buttermilk.
PCT/NL1995/000396 1994-11-23 1995-11-21 Milk product enriched with ground eggshell Ceased WO1996015678A1 (en)

Priority Applications (13)

Application Number Priority Date Filing Date Title
EP95937214A EP0801529A1 (en) 1994-11-23 1995-11-21 Milk product enriched with ground eggshell
BR9509916A BR9509916A (en) 1994-11-23 1995-11-21 Foods based on milk products
MX9703814A MX9703814A (en) 1994-11-23 1995-11-21 DAIRY PRODUCT ENRICHED WITH GROUND EGG SHELL.
JP8516752A JPH11504201A (en) 1994-11-23 1995-11-21 Dairy products fortified with crushed eggshell
SI9520125A SI9520125A (en) 1994-11-23 1995-11-21 Milk product enriched with ground eggshell
FI972188A FI972188A7 (en) 1994-11-23 1995-11-21 Dairy product enriched with powdered eggshell
SK657-97A SK65797A3 (en) 1994-11-23 1995-11-21 Food on the milk product base enriched with ground eggshell
NZ295758A NZ295758A (en) 1994-11-23 1995-11-21 Milk based food supplemented with fine-ground egg shell
HK99102958.8A HK1017828B (en) 1994-11-23 1995-11-21 Milk product enriched with ground eggshell
CZ971564A CZ156497A3 (en) 1994-11-23 1995-11-21 Eatables based on milk articles with crushed egg shells
AU39380/95A AU689342B2 (en) 1994-11-23 1995-11-21 Milk product enriched with ground eggshell
NO972357A NO972357L (en) 1994-11-23 1997-05-22 Milk products used with ground eggshells
BG101506A BG101506A (en) 1994-11-23 1997-05-23 LIQUEUR, FLAVORED WITH SMOKED EGG SHEARS

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
NL9401958A NL9401958A (en) 1994-11-23 1994-11-23 Milk product enriched with eggshell flour.
NL9401958 1994-11-23

Publications (1)

Publication Number Publication Date
WO1996015678A1 true WO1996015678A1 (en) 1996-05-30

Family

ID=19864929

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/NL1995/000396 Ceased WO1996015678A1 (en) 1994-11-23 1995-11-21 Milk product enriched with ground eggshell

Country Status (20)

Country Link
EP (1) EP0801529A1 (en)
JP (1) JPH11504201A (en)
CN (1) CN1066917C (en)
AU (1) AU689342B2 (en)
BG (1) BG101506A (en)
BR (1) BR9509916A (en)
CA (1) CA2206999A1 (en)
CZ (1) CZ156497A3 (en)
FI (1) FI972188A7 (en)
HU (1) HUT77982A (en)
LT (1) LT4266B (en)
MX (1) MX9703814A (en)
NL (1) NL9401958A (en)
NO (1) NO972357L (en)
NZ (1) NZ295758A (en)
PL (1) PL320341A1 (en)
SI (1) SI9520125A (en)
SK (1) SK65797A3 (en)
WO (1) WO1996015678A1 (en)
ZA (1) ZA959881B (en)

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL1002400C2 (en) * 1996-02-20 1997-08-21 Friesland Brands Bv Oral calcitonin preparation and method of recovering calcitonin.
KR20030023208A (en) * 2001-09-12 2003-03-19 임봉환 Watersoluble ionized calcium and fabrication method thereof
EP1522222A1 (en) * 2003-10-08 2005-04-13 Georgi Ivanov Zlatanov Milk delicacy and method for its production
NL1034964C2 (en) * 2008-01-28 2009-07-30 Friesland Brands Bv Method and compositions for the treatment of bone disorders.

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE102007022694A1 (en) * 2007-05-11 2008-11-13 Humana Milchunion Eg Milk fat milk protein composition to improve calcium absorption
CN111357814A (en) * 2018-12-25 2020-07-03 湖北神地农业科贸有限公司 Method for preparing high-calcium active lactobacillus beverage by fermenting broken rice and eggshell

Citations (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5344662A (en) * 1976-09-30 1978-04-21 Fujishima Daishiro Food composition rich in calcium
JPS5991861A (en) * 1982-11-17 1984-05-26 Bikou:Kk Calcium granule of nutrient supplementary food
JPS60259160A (en) * 1984-06-04 1985-12-21 Seiichi Watanabe Preparation of eggshell powder
JPS61199762A (en) * 1985-03-01 1986-09-04 Erika Kk Nutritive food of bone cell
EP0347899A2 (en) * 1988-06-24 1989-12-27 BIOMIN, akciová spolocnost' Pharmaceutical compositions on egg shell basis and their preparation and use
EP0449354A1 (en) * 1990-03-16 1991-10-02 Friesland (Frico Domo) Coöperatie B.A. A process for preparing a calcium enriched fermented milk beverage
JPH0576313A (en) * 1991-09-19 1993-03-30 Nakajima Nouchikusan Kenkyusho:Kk Health food manufacturing method using egg shell as raw material
JPH06167460A (en) * 1992-05-29 1994-06-14 Omron Corp Inspecting apparatus
JPH0733668A (en) * 1993-07-21 1995-02-03 Maruha Corp Bone strengthening promoter

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3558771A (en) 1968-02-12 1971-01-26 Leslie L Balassa Process for using eggshell compositions for promoting wound healing
EP0049354A3 (en) * 1980-09-08 1983-02-23 Sterling Drug Inc. Composition for therapeutic virucidal use, and articles and packages containing said composition
JPS60259161A (en) 1984-06-02 1985-12-21 Ohashi Hifumi Preparation of granular food of vitellus
JPH0691861B2 (en) 1990-09-18 1994-11-16 クリエーション・バウマン・ジャパン株式会社 Curtain material fixture

Patent Citations (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5344662A (en) * 1976-09-30 1978-04-21 Fujishima Daishiro Food composition rich in calcium
JPS5991861A (en) * 1982-11-17 1984-05-26 Bikou:Kk Calcium granule of nutrient supplementary food
JPS60259160A (en) * 1984-06-04 1985-12-21 Seiichi Watanabe Preparation of eggshell powder
JPS61199762A (en) * 1985-03-01 1986-09-04 Erika Kk Nutritive food of bone cell
EP0347899A2 (en) * 1988-06-24 1989-12-27 BIOMIN, akciová spolocnost' Pharmaceutical compositions on egg shell basis and their preparation and use
EP0449354A1 (en) * 1990-03-16 1991-10-02 Friesland (Frico Domo) Coöperatie B.A. A process for preparing a calcium enriched fermented milk beverage
JPH0576313A (en) * 1991-09-19 1993-03-30 Nakajima Nouchikusan Kenkyusho:Kk Health food manufacturing method using egg shell as raw material
JPH06167460A (en) * 1992-05-29 1994-06-14 Omron Corp Inspecting apparatus
JPH0733668A (en) * 1993-07-21 1995-02-03 Maruha Corp Bone strengthening promoter

Non-Patent Citations (8)

* Cited by examiner, † Cited by third party
Title
DATABASE WPI Derwent World Patents Index; AN 93139535 *
DATABASE WPI Week 7822, Derwent World Patents Index; AN 78-39549a *
DATABASE WPI Week 8427, Derwent World Patents Index; AN 84-168194 *
DATABASE WPI Week 9515, Derwent World Patents Index; AN 95-110552 *
PATENT ABSTRACTS OF JAPAN vol. 010, no. 136 (C - 347) *
PATENT ABSTRACTS OF JAPAN vol. 10, no. 230 (C - 365) *
PATENT ABSTRACTS OF JAPAN vol. 11, no. 24 (C - 399) *
PATENT ABSTRACTS OF JAPAN vol. 4, no. 77 (C - 013) *

Cited By (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL1002400C2 (en) * 1996-02-20 1997-08-21 Friesland Brands Bv Oral calcitonin preparation and method of recovering calcitonin.
WO1997031021A1 (en) * 1996-02-20 1997-08-28 Friesland Brands B.V. Oral calcitonin preparation and method for recovering calcitonin from eggshells
KR20030023208A (en) * 2001-09-12 2003-03-19 임봉환 Watersoluble ionized calcium and fabrication method thereof
EP1522222A1 (en) * 2003-10-08 2005-04-13 Georgi Ivanov Zlatanov Milk delicacy and method for its production
NL1034964C2 (en) * 2008-01-28 2009-07-30 Friesland Brands Bv Method and compositions for the treatment of bone disorders.
WO2009095240A1 (en) * 2008-01-28 2009-08-06 Friesland Brands B.V. Methods and compositions for the treatment of bone conditions
EA020252B1 (en) * 2008-01-28 2014-09-30 Фрисланд Брандз Б.В. Methods and compositions for the treatment of bone conditions

Also Published As

Publication number Publication date
SK65797A3 (en) 1997-10-08
AU3938095A (en) 1996-06-17
JPH11504201A (en) 1999-04-20
HK1017828A1 (en) 1999-12-03
PL320341A1 (en) 1997-09-29
AU689342B2 (en) 1998-03-26
LT97097A (en) 1997-09-25
NL9401958A (en) 1996-07-01
LT4266B (en) 1997-12-29
HUT77982A (en) 1999-03-29
CN1066917C (en) 2001-06-13
CA2206999A1 (en) 1996-05-30
NO972357D0 (en) 1997-05-22
FI972188L (en) 1997-07-22
CN1204943A (en) 1999-01-13
BR9509916A (en) 1997-09-30
BG101506A (en) 1998-01-30
MX9703814A (en) 1997-12-31
ZA959881B (en) 1996-08-13
NO972357L (en) 1997-07-22
SI9520125A (en) 1998-02-28
CZ156497A3 (en) 1997-10-15
FI972188A0 (en) 1997-05-22
NZ295758A (en) 1998-09-24
FI972188A7 (en) 1997-07-22
EP0801529A1 (en) 1997-10-22

Similar Documents

Publication Publication Date Title
US20240023579A1 (en) Dairy product and process
EP1168929B1 (en) Powdered human milk fortifier
US9386791B2 (en) Dairy product and process
EP2337558A1 (en) Nutritional composition to promote healthy development and growth
RU2468610C2 (en) Composition of milk fat and milk protein preferably etherified with palmitinic acid for calcium assimilation improvement
Kastelic et al. Studies on Growth and Survival of Calves Fed Semi-Synthetic Milks from Birth1
AU689342B2 (en) Milk product enriched with ground eggshell
Guo Human milk biochemistry and infant formula manufacturing technology
EA011075B1 (en) Dry powdered milk formula
US20040052918A1 (en) High energy complete food or nutritional supplement, method for preparing same and uses thereof
KR101356926B1 (en) Goat milk infant formula comprising humanized protein composition for improved digestibility
EP0915668A1 (en) Drinkable, acid nutrient composition with long shelf life and health-promoting action
KR20050087089A (en) Milk ingredient for forming bone and promoting absorption of calcium
Swensson et al. The prospect of obtaining beneficial mineral and vitamin contents in cow’s milk through feed
JPH1014534A (en) Nutritive composition
RU2311039C2 (en) Product for enteral feeding
Kashyap Ankit Kashyap, AK Santra, OP Dinani, Nishma Singh, Rupal Pahak, Subhrajit Das and Anupam Soni
HK40076073A (en) Dairy product and process
CN119837153A (en) Infant formula food for regulating immunity and preparation method and application thereof
JPH1146720A (en) Nutritive composition for promoting absorption of calcium

Legal Events

Date Code Title Description
WWE Wipo information: entry into national phase

Ref document number: 95196375.9

Country of ref document: CN

ENP Entry into the national phase

Ref document number: 1996 581626

Country of ref document: US

Date of ref document: 19960118

Kind code of ref document: A

AK Designated states

Kind code of ref document: A1

Designated state(s): AL AM AT AU BB BG BR BY CA CH CN CZ DE DK EE ES FI GB GE HU IS JP KE KG KP KR KZ LK LR LS LT LU LV MD MG MK MN MW MX NO NZ PL PT RO RU SD SE SG SI SK TJ TM TT UA UG US UZ VN

AL Designated countries for regional patents

Kind code of ref document: A1

Designated state(s): KE LS MW SD SZ UG AT BE CH DE DK ES FR GB GR IE IT LU MC NL PT SE BF BJ CF CG CI CM GA GN ML MR NE SN TD TG

DFPE Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101)
121 Ep: the epo has been informed by wipo that ep was designated in this application
WWE Wipo information: entry into national phase

Ref document number: PV1997-1564

Country of ref document: CZ

ENP Entry into the national phase

Ref document number: 2206999

Country of ref document: CA

Kind code of ref document: A

WWE Wipo information: entry into national phase

Ref document number: 97-00934

Country of ref document: RO

Ref document number: 972188

Country of ref document: FI

Ref document number: 1019970703434

Country of ref document: KR

Ref document number: 97-097

Country of ref document: LT

ENP Entry into the national phase

Ref document number: 1996 516752

Country of ref document: JP

Kind code of ref document: A

WWE Wipo information: entry into national phase

Ref document number: PA/a/1997/003814

Country of ref document: MX

Ref document number: 65797

Country of ref document: SK

Ref document number: 295758

Country of ref document: NZ

WWE Wipo information: entry into national phase

Ref document number: 1995937214

Country of ref document: EP

WWE Wipo information: entry into national phase

Ref document number: 1199700560

Country of ref document: VN

REG Reference to national code

Ref country code: DE

Ref legal event code: 8642

WWP Wipo information: published in national office

Ref document number: 97-097

Country of ref document: LT

WWP Wipo information: published in national office

Ref document number: PV1997-1564

Country of ref document: CZ

WWP Wipo information: published in national office

Ref document number: 1995937214

Country of ref document: EP

WWG Wipo information: grant in national office

Ref document number: 97-097

Country of ref document: LT

WWP Wipo information: published in national office

Ref document number: 1019970703434

Country of ref document: KR

WWW Wipo information: withdrawn in national office

Ref document number: 97-097

Country of ref document: LT

WWW Wipo information: withdrawn in national office

Ref document number: 1019970703434

Country of ref document: KR

WWW Wipo information: withdrawn in national office

Ref document number: 1995937214

Country of ref document: EP

WWR Wipo information: refused in national office

Ref document number: PV1997-1564

Country of ref document: CZ